| Hormonal therapy and radiation therapy in prostate cancer: 5-year outcomes from a trial evaluating combined androgen blockade with 5-alpha reductase inhibitors as an … G Rajeev-Kumar, SP Pitroda, RZ Szmulewitz, T Skolarus, SE Eggener, ... Clinical Genitourinary Cancer 22 (4), 102103, 2024 | | 2024 |
| Stockholm3 in a Multiethnic Cohort for Prostate Cancer Detection (SEPTA): A Prospective Multicentered Trial HT Vigneswaran, M Eklund, A Discacciati, T Nordström, RA Hubbard, ... Journal of Clinical Oncology, JCO. 24.00152, 2024 | | 2024 |
| Overcoming the Code Duello: Achieving Long-term Cure and Optimizing Quality of Life in Testicular Cancer CD Fankhauser, S Eggener European Urology Focus, 2024 | | 2024 |
| Health-related quality of life (HRQOL) results from PRESTO (AFT-19), a phase 3 randomized trial of intensification of androgen blockade in patients with high-risk biochemically … RC Chen, GL Mazza, B Fruth, H Xiao, J Picus, ME Taplin, TB Dorff, ... Journal of Clinical Oncology 42 (16_suppl), 5006-5006, 2024 | | 2024 |
| Ex-vivo microscopic oncotesticular sperm extraction: step-by-step surgical technique at time of radical orchiectomy CK Villota, SW Hou, C Judge, S Eggener, G Paner, OA Raheem Fertility and Sterility 121 (6), 1069-1071, 2024 | 1 | 2024 |
| Survival outcomes and molecular drivers of testicular cancer in hispanic men ME Rezaee, R Elias, HL Li, P Agrawal, M Pallauf, D Enikeev, Y Ged, ... Urologic Oncology: Seminars and Original Investigations, 2024 | | 2024 |
| Cancer Surveillance in Solid Organ Transplant Recipients With a Pretransplant History of Malignancy: Multidisciplinary Collaborative Expert Opinion KD Watt, S Rolak, DP Foley, JK Plichta, S Pruthi, D Farr, FO Zwald, ... Transplantation, 10.1097, 2024 | 1 | 2024 |
| MP41-15 GERMLINE DNA DAMAGE REPAIR GENE MUTATIONS IN EARLY STAGE PROSTATE CANCER PATIENTS UNDERGOING ACTIVE SURVEILLANCE OR DEFINITIVE LOCAL TREATMENT JT Kearns, SM Nielsen, EM Russell, C Moretz, ED Esplin, M Korn, ... The Journal of Urology 211 (5S), e680, 2024 | | 2024 |
| PD29-09 PROSTATE CANCER AND SOLID ORGAN TRANSPLANTATION: PATIENT MANAGEMENT AND OUTCOMES A Lazarovich, TW Kristof, A Dahmen, S Steadman, T Morgan, S Eggener Journal of Urology 211 (5S), e622, 2024 | | 2024 |
| PD50-10 FREE PSA AND RISK OF GLEASON GRADE GROUP≥ 2 AND FATAL PROSTATE CANCER IN BLACK MEN: IMPLICATIONS FOR RISK-STRATIFIED SCREENING K Yim, C Magnani, S Carlsson, M Shrubsole, K Penney, H Lilja, A Vickers, ... Journal of Urology 211 (5S), e1061, 2024 | | 2024 |
| MP01-12 ACCURACY OF FDG-PET SCAN IN PRIMARY TESTICULAR SEMINOMA: ANALYSIS FROM SEMS TRIAL BR Hu, M Alsyouf, C Cary, T Masterson, L Einhorn, N Adra, S Boorjian, ... Journal of Urology 211 (5S), e6, 2024 | | 2024 |
| Prospective Validation of an Automated Hybrid Multidimensional MRI Based Tool to Identify Areas for Prostate Cancer Biopsy: Preliminary results A Chatterjee, C Harmath, R Engelmann, A Devaraj, A Yousuf, S Eggener, ... | 2 | 2024 |
| Expert Perspectives on Controversies in Metastatic Castration-Resistant Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 2. D Petrylak, N Shore, D Spratt, S Tagawa, E Antonarakis, A Aparicio, ... | | 2024 |
| Expert perspectives on controversies in castration-sensitive prostate cancer management: narrative review and report of the first US prostate cancer conference part 1 ED Crawford, AH Bryce, MH Hussain, N Agarwal, H Beltran, ... JU open plus 2 (4), e00029, 2024 | 3 | 2024 |
| Expert perspectives on controversies in metastatic castration-resistant prostate cancer management: narrative review and report of the first US prostate cancer conference Part 2 AH Bryce, ED Crawford, N Agarwal, MH Hussain, H Beltran, ... JU open plus 2 (4), e00032, 2024 | 1 | 2024 |
| PRESTO: a phase III, open-label study of intensification of androgen blockade in patients with high-risk biochemically relapsed castration-sensitive prostate cancer (AFT-19) R Aggarwal, G Heller, DW Hillman, H Xiao, J Picus, ME Taplin, T Dorff, ... Journal of Clinical Oncology 42 (10), 1114-1123, 2024 | 8 | 2024 |
| Prostate cancer and solid organ transplantation: Patient management and outcomes AY Lazarovich, TW Kristof, A Dahmaen, S Steadman, T Morgan, ... European Urology 85, S341, 2024 | | 2024 |
| Risk factors for relapse in non-seminomatous testicular cancer after post-chemotherapy retroperitoneal lymph node dissection with viable residual cancer L Antonelli, D Ardizzone, I Tachibana, N Adra, C Cary, WJ Sexton, ... European Urology 85, S724-S725, 2024 | | 2024 |
| Pivotal study of MRI-guided transurethral ultrasound ablation (TULSA) of localized prostate cancer: 5-year follow up S Eggener, G Zagaja, A Oto, C Pavlovich, K Macura, M Koch, T Gardner, ... Urologic Oncology: Seminars and Original Investigations 42, S83, 2024 | 4 | 2024 |
| Stockholm3 validation in a multi-ethnic cohort for prostate cancer (SEPTA) detection: A multicentered, prospective trial. HT Vigneswaran, M Eklund, A Discacciati, T Nordström, RA Hubbard, ... Journal of Clinical Oncology 42 (4_suppl), 262-262, 2024 | 5 | 2024 |
